Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force
JS Smolen, FC Breedveld, GR Burmester… - Annals of the …, 2016 - ard.bmj.com
Background Reaching the therapeutic target of remission or low-disease activity has
improved outcomes in patients with rheumatoid arthritis (RA) significantly. The treat-to-target …
improved outcomes in patients with rheumatoid arthritis (RA) significantly. The treat-to-target …
[HTML][HTML] The global challenges and opportunities in the practice of rheumatology: white paper by the World Forum on Rheumatic and Musculoskeletal Diseases
M Al Maini, F Adelowo, J Al Saleh, Y Al Weshahi… - Clinical …, 2015 - Springer
Rheumatic and musculoskeletal diseases (RMDs) represent a multitude of degenerative,
inflammatory and auto-immune conditions affecting millions of people worldwide. Persons …
inflammatory and auto-immune conditions affecting millions of people worldwide. Persons …
Sex differences in pain scores and localization in inflammatory arthritis: a systematic review and metaanalysis
C Barnabe, L Bessette, C Flanagan… - The Journal of …, 2012 - jrheum.org
Objective. To systematically identify and examine reports of sex-stratified pain
measurements in patients with inflammatory arthritis. Methods. Data sources included …
measurements in patients with inflammatory arthritis. Methods. Data sources included …
Intraarticular corticosteroids, supervised physiotherapy, or a combination of the two in the treatment of adhesive capsulitis of the shoulder: A placebo‐controlled trial
S Carette, H Moffet, J Tardif, L Bessette… - Arthritis & …, 2003 - Wiley Online Library
Objective To compare the efficacy of a single intraarticular corticosteroid injection, a
supervised physiotherapy program, a combination of the two, and placebo in the treatment …
supervised physiotherapy program, a combination of the two, and placebo in the treatment …
Canadian Rheumatology Association recommendations for pharmacological management of rheumatoid arthritis with traditional and biologic disease-modifying …
VP Bykerk, P Akhavan, GS Hazlewood… - The Journal of …, 2012 - jrheum.org
Objective. The Canadian Rheumatology Association (CRA) has developed
recommendations for the pharmacological management of rheumatoid arthritis (RA) with …
recommendations for the pharmacological management of rheumatoid arthritis (RA) with …
Canadian Rheumatology Association recommendations for the pharmacological management of rheumatoid arthritis with traditional and biologic disease-modifying …
C Bombardier, GS Hazlewood, P Akhavan… - The Journal of …, 2012 - jrheum.org
Objective. The Canadian Rheumatology Association (CRA) has developed
recommendations for the pharmacological management of rheumatoid arthritis (RA) with …
recommendations for the pharmacological management of rheumatoid arthritis (RA) with …
2014 Update of the Canadian Rheumatology Association/Spondyloarthritis Research Consortium of Canada treatment recommendations for the management of …
S Rohekar, J Chan, ML Shirley, N Haroon… - The Journal of …, 2015 - jrheum.org
Objective. The Canadian Rheumatology Association (CRA) and the Spondyloarthritis
Research Consortium of Canada (SPARCC) have collaborated to update the …
Research Consortium of Canada (SPARCC) have collaborated to update the …
Sirukumab for rheumatoid arthritis: the phase III SIRROUND-D study
T Takeuchi, C Thorne, G Karpouzas, S Sheng… - Annals of the …, 2017 - ard.bmj.com
Objectives Interleukin-6 (IL-6) is implicated in rheumatoid arthritis (RA) pathophysiology.
Unlike IL-6 receptor inhibitors, sirukumab is a human monoclonal antibody that selectively …
Unlike IL-6 receptor inhibitors, sirukumab is a human monoclonal antibody that selectively …
Treatment preferences of patients with early rheumatoid arthritis: a discrete-choice experiment
GS Hazlewood, C Bombardier, G Tomlinson… - …, 2016 - academic.oup.com
Objective. To quantify the preferences of patients with early RA (ERA) with the benefits and
harms of DMARDs. Methods. We assessed patients' preferences using a discrete-choice …
harms of DMARDs. Methods. We assessed patients' preferences using a discrete-choice …
The Scleroderma Patient-Centered Intervention Network Cohort: baseline clinical features and comparison with other large scleroderma cohorts
DH Dougherty, L Kwakkenbos, ME Carrier… - …, 2018 - academic.oup.com
Abstract Objectives The Scleroderma Patient-centered Intervention Network (SPIN) Cohort is
a web-based cohort designed to collect patient-reported outcomes at regular intervals as a …
a web-based cohort designed to collect patient-reported outcomes at regular intervals as a …